|
Q1 2025
|
73 |
2,093,216 |
IBN, HDB, MELI, TEAM
|
13F-HR
|
5/15/2025 |
000117266125002305 |
|
Q4 2024
|
80 |
2,423,258 |
MELI, HDB, IBN, FTI
|
13F-HR
|
2/4/2025 |
000117266125000481 |
|
Q3 2024
|
77 |
2,551,154 |
MELI, FTI, HDB, IBN
|
13F-HR
|
10/30/2024 |
000117266124004413 |
|
Q2 2024
|
74 |
2,586,568 |
MELI, FTI, HDB, IBN
|
13F-HR
|
8/14/2024 |
000117266124003369 |
|
Q1 2024
|
76 |
2,898,617 |
MELI, FTI, IBN, TEAM
|
13F-HR
|
5/6/2024 |
000117266124002010 |
|
Q4 2023
|
74 |
3,114,994 |
MELI, FTI, APTV, ALKS
|
13F-HR
|
1/29/2024 |
000117266124000368 |
|
Q3 2023
|
75 |
2,980,792 |
FTI, MELI, TEAM, BABA
|
13F-HR
|
10/20/2023 |
000117266123003469 |
|
Q2 2023
|
76 |
3,084,916 |
FTI, ALKS, 0A2P.IL, IBN
|
13F-HR
|
8/11/2023 |
000117266123002920 |
|
Q1 2023
|
73 |
3,060,105 |
FTI, 0A2P.IL, ALKS, MELI
|
13F-HR
|
5/5/2023 |
000117266123001855 |
|
Q4 2022
|
75 |
2,553,863 |
FTI, IBN, 0A2P.IL, APTV
|
13F-HR
|
2/3/2023 |
000117266123000429 |
|
Q3 2022
|
77 |
2,222,059 |
APTV, IBN, ALKS, 0A2P.IL
|
13F-HR
|
11/2/2022 |
000117266122002273 |
|
Q2 2022
|
79 |
2,355,834 |
APTV, IBN, ALKS, TEAM.MX
|
13F-HR
|
8/2/2022 |
000117266122001705 |
|
Q1 2022
|
78 |
3,114,464 |
IBN, APTV, TEAM.MX, 0A2P.IL
|
13F-HR
|
5/12/2022 |
000117266122001252 |
|
Q4 2021
|
77 |
3,708,143 |
APTV, TEAM.MX, IBN, 0A2P.IL
|
RESTATEMENT
|
3/23/2022 |
000117266122001036 |
|
Q3 2021
|
75 |
3,718,758 |
IBN, APTV, TEAM.MX, 0A2P.IL
|
13F-HR
|
11/12/2021 |
000117266121002161 |
|
Q2 2021
|
77 |
4,130,899 |
TEAM.MX, APTV, IBN, TSM
|
13F-HR
|
8/9/2021 |
000117266121001595 |
|
Q1 2021
|
77 |
3,512,858 |
0A2P.IL, APTV, IBN, TEAM.MX
|
13F-HR
|
5/12/2021 |
000117266121001093 |
|
Q4 2020
|
79 |
3,446,773 |
TEAM.MX, 0A2P.IL, BABA, APTV
|
13F-HR
|
2/11/2021 |
000117266121000315 |
|
Q3 2020
|
76 |
2,671,542 |
BABA, TEAM.MX, 0A2P.IL, ASML
|
13F-HR
|
11/16/2020 |
000117266120002154 |
|
Q2 2020
|
75 |
2,269,705 |
BABA, 0A2P.IL, ASML, IBN
|
13F-HR
|
7/23/2020 |
000117266120001551 |
|
Q1 2020
|
73 |
1,718,938 |
BABA, ASML, IBN, 0A2P.IL
|
13F-HR
|
5/4/2020 |
000117266120001126 |
|
Q4 2019
|
69 |
2,478,439 |
BABA, IBN, 0A2P.IL, ASML
|
13F-HR
|
2/5/2020 |
000117266120000318 |
|
Q3 2019
|
67 |
2,184,107 |
BABA, IBN, 0A2P.IL, ASML
|
13F-HR
|
10/30/2019 |
000117266119002085 |
|
Q2 2019
|
70 |
2,255,814 |
IBN, 0A2P.IL, BABA, QGEN
|
13F-HR
|
8/5/2019 |
000117266119001614 |
|
Q1 2019
|
71 |
2,277,679 |
0A2P.IL, IBN, BABA, QGEN
|
13F-HR
|
5/3/2019 |
000117266119001101 |
|
Q4 2018
|
69 |
1,932,795 |
HDB, 0A2P.IL, BABA, QGEN
|
13F-HR
|
2/6/2019 |
000117266119000318 |
|
Q3 2018
|
69 |
2,319,653 |
AVGO, BABA, 0A2P.IL, HDB
|
13F-HR
|
10/18/2018 |
000117266118001866 |
|
Q2 2018
|
71 |
2,366,165 |
HDB, AVGO, 0A2P.IL, BABA
|
13F-HR
|
7/18/2018 |
000117266118001397 |
|
Q1 2018
|
72 |
2,350,927 |
HDB, AVGO, 0A2P.IL, BABA
|
13F-HR
|
4/30/2018 |
000117266118000979 |
|
Q4 2017
|
72 |
2,360,397 |
HDB, AVGO, BABA, 0A2P.IL
|
13F-HR
|
1/26/2018 |
000117266118000208 |
|
Q3 2017
|
71 |
2,343,303 |
HDB, BABA, AVGO, AGN
|
13F-HR
|
10/30/2017 |
000117266117001857 |
|
Q2 2017
|
76 |
2,317,091 |
HDB, AGN, AVGO, BABA
|
RESTATEMENT
|
8/14/2017 |
000117266117001659 |
|
Q1 2017
|
76 |
2,225,433 |
AVGO, AGN, NXPI, HDB
|
13F-HR
|
5/10/2017 |
000117266117000981 |
|
Q4 2016
|
77 |
2,049,924 |
AVGO, NXPI, AGN, HDB
|
13F-HR
|
2/8/2017 |
000117266117000281 |
|
Q3 2016
|
78 |
2,197,814 |
NXPI, AVGO, AGN, HDB
|
13F-HR
|
10/24/2016 |
000117266116004058 |
|
Q2 2016
|
76 |
1,964,737 |
NXPI, AVGO, AGN, MBLY
|
13F-HR
|
7/27/2016 |
000117266116003623 |
|
Q1 2016
|
77 |
1,702,350 |
NXPI, BIDU, ASML, MBLY
|
13F-HR
|
5/2/2016 |
000117266116003150 |
|
Q4 2015
|
72 |
1,509,412 |
QGEN, NXPI, BIDU, HDB
|
13F-HR
|
2/9/2016 |
000117266116002498 |
|
Q3 2015
|
73 |
1,504,481 |
QGEN, NXPI, HDB, ASML
|
13F-HR
|
11/10/2015 |
000117266115001906 |
|
Q2 2015
|
77 |
1,670,200 |
NXPI, QGEN, BIDU, ASML
|
13F-HR
|
8/11/2015 |
000117266115001460 |
|
Q1 2015
|
78 |
1,655,536 |
NXPI, QGEN, BIDU, ASML
|
13F-HR
|
5/8/2015 |
000117266115001003 |
|
Q4 2014
|
79 |
1,848,736 |
NXPI, BIDU, QGEN, ASML
|
13F-HR
|
2/4/2015 |
000117266115000237 |
|
Q3 2014
|
80 |
1,809,924 |
NXPI, QGEN, ETN, ASML
|
13F-HR
|
11/12/2014 |
000117266114001713 |
|
Q2 2014
|
81 |
1,872,914 |
NXPI, DEO, QGEN, ASML
|
13F-HR
|
8/12/2014 |
000117266114001346 |
|
Q1 2014
|
80 |
1,711,371 |
DEO, ASML, ETN, NXPI
|
13F-HR
|
5/15/2014 |
000117266114001094 |
|
Q4 2013
|
78 |
1,523,430 |
DEO, ASML, QGEN, MR
|
13F-HR
|
2/10/2014 |
000117266114000293 |